DOMPE logo

DOMPE

Europe, Lombardia, Italy, Milan

Description

DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs.

Investor Profile

DOMPE has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Ghana, United Kingdom, Italy.
  • Strong thematic focus on Health Care, Biotechnology, Hospital.

Stage Focus

  • Series C (33%)
  • Series A (33%)
  • Series Unknown (33%)

Country Focus

  • Ghana (33%)
  • United Kingdom (33%)
  • Italy (33%)

Industry Focus

  • Health Care
  • Biotechnology
  • Hospital
  • Pharmaceutical
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DOMPE frequently co-invest with?

Unbound
Europe, England, United Kingdom, London
Co-Investments: 1
Acuity Ventures
North America, California, United States, San Jose
Co-Investments: 1
AV
Europe, Istanbul, Turkey, Istanbul
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
northstar.vc
Europe, England, United Kingdom, London
Co-Investments: 1
JF
North America, California, United States, Los Angeles
Co-Investments: 1
Co-Investments: 1
Novastar Ventures
Africa, Nairobi Area, Kenya, Nairobi
Co-Investments: 1
CDC Group
Europe, England, United Kingdom, London
Co-Investments: 1
Breyer Capital
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does DOMPE often collaborate with?

JB
North America, California, United States, Menlo Park
Shared Deals: 1
CG
Europe, England, United Kingdom, London
Shared Deals: 1
DV
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1

What are some of recent deals done by DOMPE?

Engitix

London, England, United Kingdom

Engitix is operates as a tissue engineering company.

BiotechnologyHealth CareLife Science
Series AJan 19, 2022
Amount Raised: $54,000,000
mPharma

Accra, Greater Accra, Ghana

mPharma offers solutions to health insurance and pharmaceutical companies to make it easier for patients to afford their medications.

Health CareHospitalPharmaceutical
Series CMay 26, 2020
Amount Raised: $18,520,000
Philogen

Sovicille, Toscana, Italy

Philogen is a Swiss-Italian integrated biotechnology company.

BiopharmaBiotechnology
Series UnknownMay 14, 2019
Amount Raised: $69,460,783